Inhibition of P450 17 as a New Strategy for the Treatment of Prostate Cancer

E-ISSN： 1875-533x|12|14|1623-1629

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.14, 2005-07, pp. : 1623-1629

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP17 Inhibitors for Prostate Cancer Treatment - An Update

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 868-899

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Cytochromes P450: Existing and New Promising Therapeutic Targets

By Schuster Inge Bernhardt Rita

Drug Metabolism Reviews, Vol. 39, Iss. 2-3, 2007-04 ,pp. : 481-499

Informa Healthcare

Access to resources Recommend Favorite

New Discoveries in Prostate Cancer Biology and Treatment

By Cooper Carlton R Chay Christopher H Pienta Kenneth J

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 123-127

Informa Healthcare

Access to resources Recommend Favorite

New Features in the Treatment of Androgen-Independent Prostate Cancer

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite